PARSIPPANY, N.J., July 26, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the merger between Perrigo Com
PARSIPPANY, N.J., July 26, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the merger between Perrigo Com
Settlement Order Requires Sale of Six Generic Drugs to Watson Pharmaceuticals, Preserves Competition for a Future Generic Drug. The Federal Trade Commission will require generic drug manufacturers Perrigo Company and Paddock Laboratories, Inc. to sell six
MAPLE GROVE, Minn., July 26, 2011 /PRNewswire/ -- Rough patches of dry, flaky skin on your elbows and knees are your body's call to arms to start protecting them from severe dry skin with AmLactin XL® Moisturizing Lotion. AmLactin XL® contains a unique
Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the merger between Perrigo Company and Paddock Laboratories.